Similarly, in the present study, C-IMT was applied to detection of subclinical atherosclerosis20 in order to evaluate whether serum FGF23 levels can be used to identify subclinical atherosclerosis in the first-degree relatives of patients with diabetes. The gene discussed is FGF23; the disease is diabetes mellitus.